Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Gastrointestinal Therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Gastrointestinal Therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Gastrointestinal Therapeutics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Gastrointestinal Therapeutics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gastrointestinal Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gastrointestinal Therapeutics Market Dynamics
3.1. Gastrointestinal Therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in prevalence of gastrointestinal diseases
3.1.1.2. Rise in geriatric population
3.1.1.3. Rise in the number of product launches
3.1.2. Market Challenges
3.1.2.1. Stringent government regulations toward approval of biosimilars
3.1.2.2. Expiration of the drugs patent
3.1.3. Market Opportunities
3.1.3.1. Rise in Research & Development activities
3.1.3.2. Growth opportunities in emerging markets
Chapter 4. Global Gastrointestinal Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Gastrointestinal Therapeutics Market, by Drug Class
5.1. Market Snapshot
5.2. Global Gastrointestinal Therapeutics Market by Drug Class, Performance – Potential Analysis
5.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
5.4.1. Biologics
5.4.2. Proton Pump Inhibitors
5.4.3. Aminosalicylates
5.4.4. Antacids
5.4.5. Laxatives
5.4.6. H2 Antagonists
5.4.7. Others
Chapter 6. Global Gastrointestinal Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global Gastrointestinal Therapeutics Market by Application, Performance – Potential Analysis
6.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
6.4.1. Inflammatory Bowel Disease
6.4.2. Gastroesophageal Reflux Disease
6.4.3. Peptic Ulcer Disease
6.4.4. Irritable Bowel Syndrome
6.4.5. Others
Chapter 7. Global Gastrointestinal Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Gastrointestinal Therapeutics Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Drug Stores
7.4.3. Retail Pharmacies
7.4.4. Online Providers
Chapter 8. Global Gastrointestinal Therapeutics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Gastrointestinal Therapeutics Market, Regional Market Snapshot
8.4. North America Gastrointestinal Therapeutics Market
8.4.1. U.S. Gastrointestinal Therapeutics Market
8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Gastrointestinal Therapeutics Market
8.5. Europe Gastrointestinal Therapeutics Market Snapshot
8.5.1. U.K. Gastrointestinal Therapeutics Market
8.5.2. Germany Gastrointestinal Therapeutics Market
8.5.3. France Gastrointestinal Therapeutics Market
8.5.4. Spain Gastrointestinal Therapeutics Market
8.5.5. Italy Gastrointestinal Therapeutics Market
8.5.6. Rest of Europe Gastrointestinal Therapeutics Market
8.6. Asia-Pacific Gastrointestinal Therapeutics Market Snapshot
8.6.1. China Gastrointestinal Therapeutics Market
8.6.2. India Gastrointestinal Therapeutics Market
8.6.3. Japan Gastrointestinal Therapeutics Market
8.6.4. Australia Gastrointestinal Therapeutics Market
8.6.5. South Korea Gastrointestinal Therapeutics Market
8.6.6. Rest of Asia Pacific Gastrointestinal Therapeutics Market
8.7. Latin America Gastrointestinal Therapeutics Market Snapshot
8.7.1. Brazil Gastrointestinal Therapeutics Market
8.7.2. Mexico Gastrointestinal Therapeutics Market
8.8. Middle East & Africa Gastrointestinal Therapeutics Market
8.8.1. Saudi Arabia Gastrointestinal Therapeutics Market
8.8.2. South Africa Gastrointestinal Therapeutics Market
8.8.3. Rest of Middle East & Africa Gastrointestinal Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bristol-Myers Squibb Company
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. AbbVie Inc.
9.3.3. Pfizer Inc.
9.3.4. AstraZeneca plc
9.3.5. Bayer AG
9.3.6. Takeda Pharmaceutical Company Limited
9.3.7. Organon Group of Companies
9.3.8. Bausch Health Companies Inc.
9.3.9. Cosmo Pharmaceuticals N.V.
9.3.10. Teva Pharmaceutical Industries Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
